Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
CYTK News
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
New insider activity at Cytokinetics ( (CYTK) ) has taken place on April 23, 2025. Fady Ibraham Malik, the Executive Vice President of Research & Development a...
Recent label updates for Bristol Myers’ (BMY) Camzyos should read positively for obstructive hypertrophic cardiomyopathy patients and physicians, as they could...
Analyst ratings
87%
of 23 ratingsMore CYTK News
Jason Zemansky, an analyst from Bank of America Securities, maintained the Hold rating on Cytokinetics (CYTK – Research Report). The associated price target rem...
Insiders have been trading these 5 stocks: ((CYTK)), ((BJ)), ((GTE)), ((PBF)) and ((IMVT)). Here is a breakdown of their recent trades and their value. In a no...